All News #Library
Biotech
Alchemab Starts Phase 1 Trial of ATLX-1282, Extends Financing
09 Sep 2025 //
PR NEWSWIRE
Eli Lilly licenses ALS drug program from Alchemab in $415M pact
07 May 2025 //
FIERCE PHARMA
Alchemab, Lilly Collaborate to Develop Therapies for ALS
09 Jan 2025 //
PR NEWSWIRE
Alchemab appoints Co-Founder Jane Osbourn as Chief Executive Officer
12 Sep 2024 //
PR NEWSWIRE

Market Place
Sourcing Support